Cholesterol, blood pressure, mammograms — these are just a few of the health screenings women should get. Find out how often you need them and when.

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare ...

Natera delivers robust revenue growth, raising 2026 guidance to $2.74–$2.82 billion, but remains unprofitable. Read more on ...

Men often skip medical care, risking silent health issues. Discover how early check-ups and partner support can make all the difference.

Mediaplanet today announces the launch of its latest Digestive Health campaign, distributed nationwide within USA TODAY and ...

They told me it was effective, and I knew mailing a Cologuard box back would be pretty dang easy.” Cologuard — a simple way ...

CancerCare Manitoba is encouraging more Manitobans to take part in routine colorectal cancer screening, particularly in ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

Bryce Ramsey of Madison, Mississippi, was 33 when she was diagnosed with colorectal cancer. Upon noticing blood in her stool, ...

A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths from the disease.

With an FDA approval for its companion diagnostic in bladder cancer, Natera extends its Treatment on MRD strategy, deferring ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.